Startups

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

Summary

Seedtable Score
  • 15
Locations
Company Size
  • 11 to 50 employees
Last Stage Round

Total funding Amount

$110M

Fundraising History

Investors